An observational study in Heart Arrhythmias, sponsored by Yale University. Completed at 54 sites in 14 countries. Open to participants aged 10 Years to 60 Years. Per ClinicalTrials.gov, last updated 2015-06-11.
Sponsored by Yale University · Observational
The registry will obtain information to determine the safety of sports participation for patients with defibrillators (ICDs).
Patients who are participating in sports who have defibrillators will be invited to participate in a prospective registry to determine the rate of adverse events occurring during sporting activities. Patients will be followed for four years and adverse events quantified. Yale is the coordinating center for this multicenter registry.
885 studies on the registry are indexed under Arrhythmias, Cardiac; 235 are open to participants now.
This study's enrollment of 400 is above the median of 200 across 414 observational studies indexed under Arrhythmias, Cardiac.
Browse Arrhythmias, Cardiac studies →Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.
Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.
Counted across the registry records on this site, refreshed daily.
Individuals between the ages of 10 and 60 years who have defibrillators who participate in competitive (organized sports at any level) or dangerous sports.
Exclusion Criteria:
Resuscitated arrest or death during sports, or injury during sports due to arrhythmic symptoms and/or shock.
Time frame: four years
System malfunction and incidence of ventricular arrhythmias (VA) requiring multiple shocks for termination
Time frame: four years.
This study is completed, as verified in Jun 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yale University